member of
- American Association for Cancer Research Associate Member Council - Member 2024 - 2027
Filippo Pederzoli Postdoctoral Associate in Pathology and Laboratory Medicine
- Postdoctoral Associate in Pathology and Laboratory Medicine, Pathology and Laboratory Medicine , Weill Cornell Medical College 2022 -
Affiliation
Publications
Sort by
selected publications
- Gold nanorod-assisted theranostic solution for nonvisible residual disease in bladder cancer. Proceedings of the National Academy of Sciences of the United States of America. 2024 Academic Article GET IT
- Topographic modification of the extracellular matrix precedes the onset of bladder cancer. Matrix biology plus. 2024 Academic Article GET IT
- Distinct mesenchymal cell states mediate prostate cancer progression. Nature communications. 2024 Academic Article GET IT
- Stool Microbiome Signature Associated with Response to Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Cancer. European urology. 2024 Academic Article GET IT
- Progressive alteration of murine bladder elasticity in actinic cystitis detected by Brillouin microscopy. Scientific reports. 2024 Academic Article GET IT
- Whole exome data prioritization unveils the hidden weight of Mendelian causes of male infertility. A report from the first Italian cohort. PloS one. 2023 Academic Article GET IT
- Predicting Limited Survival Following Inguinal Lymph Node Dissection in Penile Cancer: Should we revisit the goals of care?. Urology. 2023 Academic Article GET IT
- Micro-mechanical fingerprints of the rat bladder change in actinic cystitis and tumor presence. Communications biology. 2023 Academic Article GET IT
- Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer. Journal of translational medicine. 2023 Academic Article GET IT
- Concomitant vs Staged Therapeutic Inguinal Lymphadenectomy in Clinically Node Positive Penile Squamous Cell Carcinoma: Does It Make a Difference?. The Journal of urology. 2023 Academic Article GET IT
- "Stromal cells in prostate cancer pathobiology: friends or foes?". British journal of cancer. 2022 Review GET IT
- Circulating Cell-Free DNA in Renal Cell Carcinoma: The New Era of Precision Medicine. Cancers. 2022 Review GET IT
- Early diagnosis of bladder cancer by photoacoustic imaging of tumor-targeted gold nanorods. Photoacoustics. 2022 Academic Article GET IT
- Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review. Urologic oncology. 2022 Review GET IT
- The Pros and Cons of "Machination of Medicine" in Genitourinary Oncology Practice. Bladder cancer (Amsterdam, Netherlands). 2022 Editorial Article GET IT
- A global approach to improving penile cancer care. Nature reviews. Urology. 2021 Review GET IT
- Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints. Urologic oncology. 2021 Review GET IT
- Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma. Urologic oncology. 2021 Academic Article GET IT
-
Risk of health status worsening in primary infertile men: A prospective 10-year follow-up study.
Andrology.
2021
Academic Article
GET IT
Times cited: 3 -
Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia.
Nature communications.
2021
Academic Article
GET IT
Times cited: 36 -
Testicular volume in infertile versus fertile white-European men: a case-control investigation in the real-life setting.
Asian journal of andrology.
2021
Academic Article
GET IT
Times cited: 28 -
Causal contributors to tissue stiffness and clinical relevance in urology.
Communications biology.
2021
Review
GET IT
Times cited: 38 - Reply by Authors. The Journal of urology. 2021 Comment GET IT
- Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study). Clinical Medicine Insights. Oncology. 2021 Academic Article GET IT
-
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02.
Urologic oncology.
2021
Academic Article
GET IT
Times cited: 2 - High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors?. Current problems in cancer. 2021 Review GET IT
-
Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab?.
European urology.
2021
Academic Article
GET IT
Times cited: 4 -
Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies.
The Journal of urology.
2021
Academic Article
GET IT
Times cited: 1 -
Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand?.
Urologic oncology.
2021
Review
GET IT
Times cited: 1 -
Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer.
Journal of the National Cancer Institute.
2021
Academic Article
GET IT
Times cited: 31 -
Perioperative and oncologic outcomes of open radical nephrectomy and inferior vena cava thrombectomy with liver mobilization and Pringle maneuver for Mayo III level tumor thrombus: single institution experience.
Minerva urology and nephrology.
2020
Academic Article
GET IT
Times cited: 1 -
Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma.
European urology oncology.
2020
Academic Article
GET IT
Times cited: 3 -
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy.
European urology focus.
2020
Academic Article
GET IT
Times cited: 2 -
Normal sperm parameters per se do not reliably account for fertility: A case-control study in the real-life setting.
Andrologia.
2020
Academic Article
GET IT
Times cited: 5 -
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab.
Urologic oncology.
2020
Academic Article
GET IT
Times cited: 3 -
Targetable gene fusions and aberrations in genitourinary oncology.
Nature reviews. Urology.
2020
Review
GET IT
Times cited: 13 -
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆.
Annals of oncology : official journal of the European Society for Medical Oncology.
2020
Academic Article
GET IT
Times cited: 17 -
Contemporary Treatment Patterns and Outcomes for Patients with Penile Squamous Cell Carcinoma: Identifying Management Gaps to Promote Multi-institutional Collaboration.
European urology oncology.
2020
Letter
GET IT
Times cited: 2 - Re: Siamak Daneshmand, Azadeh Nazemi. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. Eur Urol Focus 2020;6:639-41. European urology focus. 2020 Letter GET IT
-
Infertile Men Have Higher Prostate-specific Antigen Values than Fertile Individuals of Comparable Age.
European urology.
2020
Academic Article
GET IT
Times cited: 3 -
A risk calculator predicting recurrence in lymph node metastatic penile cancer.
BJU international.
2020
Academic Article
GET IT
Times cited: 7 - The new era of precision urobiome: RE: "Characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study" by Chipollini et al. Urologic oncology. 2020 Letter GET IT
-
The Value of Multiparametric Magnetic Resonance Imaging Sequences to Assist in the Decision Making of Muscle-invasive Bladder Cancer.
European urology oncology.
2020
Academic Article
GET IT
Times cited: 6 -
Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study.
European urology oncology.
2020
Academic Article
GET IT
Times cited: 4 -
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients.
European urology oncology.
2020
Academic Article
GET IT
Times cited: 11 -
Semen infections in men with primary infertility in the real-life setting.
Fertility and sterility.
2020
Academic Article
GET IT
Times cited: 10 -
Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinoma.
BJU international.
2020
Academic Article
GET IT
Times cited: 7 -
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer.
European urology.
2020
Academic Article
GET IT
Times cited: 51 -
Neoadjuvant chemotherapy for lymph node-positive penile cancer: current evidence and knowledge.
Current opinion in urology.
2020
Review
GET IT
Times cited: 1 -
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study.
Clinical genitourinary cancer.
2020
Academic Article
GET IT
Times cited: 18 -
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study.
European urology.
2019
Academic Article
GET IT
Times cited: 38 -
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies.
European urology.
2019
Academic Article
GET IT
Times cited: 107 - Editorial Comment. The Journal of urology. 2019 Comment GET IT
-
Heavy cigarette smoking and alcohol consumption are associated with impaired sperm parameters in primary infertile men.
Asian journal of andrology.
2019
Academic Article
GET IT
Times cited: 67 -
Incremental Utility of Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Quantifying the Relapse Risk Associated with Therapeutic Effect.
European urology.
2019
Academic Article
GET IT
Times cited: 13 -
Regenerative and engineered options for urethroplasty.
Nature reviews. Urology.
2019
Review
GET IT
Times cited: 14 -
Diagnosis of urothelial carcinoma in situ using blue light cystoscopy and the utility of immunohistochemistry in blue light-positive lesions diagnosed as atypical.
Human pathology.
2019
Academic Article
GET IT
Times cited: 7 -
Impaired testicular signaling of vitamin A and vitamin K contributes to the aberrant composition of the extracellular matrix in idiopathic germ cell aplasia.
Fertility and sterility.
2019
Academic Article
GET IT
Times cited: 9 -
High-risk human papillomavirus in semen is associated with poor sperm progressive motility and a high sperm DNA fragmentation index in infertile men.
Human reproduction (Oxford, England).
2019
Academic Article
GET IT
Times cited: 28 -
Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology.
World journal of urology.
2019
Academic Article
GET IT
Times cited: 6 -
The duration of infertility affects semen parameters in primary infertile men: results of a single-centre, cross-sectional study.
BJU international.
2018
Academic Article
GET IT
Times cited: 4 -
Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate.
Molecular cancer research : MCR.
2018
Academic Article
GET IT
Times cited: 46 -
Undiagnosed prediabetes is highly prevalent in primary infertile men - results from a cross-sectional study.
BJU international.
2018
Academic Article
GET IT
Times cited: 11 -
Clinical Profile of Young Patients with Erectile Dysfunction: Preliminary Findings of a Real-life Cross-sectional Study.
European urology focus.
2018
Academic Article
GET IT
Times cited: 7 - Multiple PDE5Is use as a marker of decreased overall men's health: A real-life study. PloS one. 2018 Academic Article GET IT
-
High Blood Pressure Is a Highly Prevalent but Unrecognised Condition in Primary Infertile Men: Results of a Cross-sectional Study.
European urology focus.
2018
Academic Article
GET IT
Times cited: 15 -
Unrecognized Prediabetes Is Highly Prevalent in Men With Erectile Dysfunction-Results From a Cross-Sectional Study.
The journal of sexual medicine.
2018
Academic Article
GET IT
Times cited: 7 -
The role of neutrophil-to-lymphocyte ratio in men with erectile dysfunction-preliminary findings of a real-life cross-sectional study.
Andrology.
2018
Academic Article
GET IT
Times cited: 10 -
Age at First Presentation for Erectile Dysfunction: Analysis of Changes over a 12-yr Period.
European urology focus.
2018
Academic Article
GET IT
Times cited: 11 -
Surgical Factors Associated With Male and Female Sexual Dysfunction After Radical Cystectomy: What Do We Know and How Can We Improve Outcomes?.
Sexual medicine reviews.
2018
Review
GET IT
Times cited: 13 -
Anti-Mullerian Hormone-to-Testosterone Ratio is Predictive of Positive Sperm Retrieval in Men with Idiopathic Non-Obstructive Azoospermia.
Scientific reports.
2017
Academic Article
GET IT
Times cited: 44 -
Does Calculated Free Testosterone Overcome Total Testosterone in Protecting From Sexual Symptom Impairment? Findings of a Cross-Sectional Study.
The journal of sexual medicine.
2017
Academic Article
GET IT
Times cited: 6 -
Long-term penile morphometric alterations in patients treated with robot-assisted versus open radical prostatectomy.
Andrology.
2017
Academic Article
GET IT
Times cited: 5 -
Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone.
Scientific reports.
2017
Academic Article
GET IT
Times cited: 16 -
Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer.
Bladder cancer (Amsterdam, Netherlands).
2017
Academic Article
GET IT
Times cited: 65 -
Depressive Symptoms and Low Sexual Desire after Radical Prostatectomy: Early and Long-Term Outcomes in a Real-Life Setting.
The Journal of urology.
2017
Academic Article
GET IT
Times cited: 17 -
Analysis of Hospital Readmissions After Prosthetic Urologic Surgery in the United States: Nationally Representative Estimates of Causes, Costs, and Predictive Factors.
The journal of sexual medicine.
2017
Academic Article
GET IT
Times cited: 2 -
Primary, secondary and compensated hypogonadism: a novel risk stratification for infertile men.
Andrology.
2017
Academic Article
GET IT
Times cited: 23 -
Sexual functioning mirrors overall men's health status, even irrespective of cardiovascular risk factors.
Andrology.
2017
Academic Article
GET IT
Times cited: 15 -
When to Perform Karyotype Analysis in Infertile Men? Validation of the European Association of Urology Guidelines with the Proposal of a New Predictive Model.
European urology.
2016
Academic Article
GET IT
Times cited: 28
Research
Sort by
Funding awarded
- Loss of Stromal Androgen Receptor (AR) Signaling Contributes to Progression in Prostate Cancer Principal Investigator 2023 - 2024
- missing activity Principal Investigator 2022 - 2024
Service
outreach and community service activities
- Postdoctoral Association (PDA), Weill Cornell Medicine Member, Science Outreach Committee 2022 - 2023
Background
education and training
- Ph.D., San Raffaele University (Italy) 21
- M.D., San Raffaele University School of Medicine(Italy) 2017
awards and honors
- Resident Corner Award, conferred by European Urology, the official journal of the European Association of Urology (EAU), 2022
- Conquer Cancer Annual Meeting Merit Award, conferred by ASCO (American Society of Clinical Oncology) Foundation, 2021
- Cancer Immunotherapy Winter School Travel Award, conferred by Society for Immunotherapy of Cancer (SITC), 2021
- Simona Morone Prize, conferred by Fondazione Ricerca Molinette Onlus, Associazione “Guarda oltre ciò che vedi”, 2020
Contact
full name
- Filippo Pederzoli
primary email
- fip4001@med.cornell.edu
phone
- +1 (646) 962-5042